EI
CTSO icon

EAM Investors’s Cytosorbents Corp CTSO Stock Holding History

EAM Investors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-164,400
Closed -$1.63M – 296
2020
Q2 		$1.63M Buy
164,400
+28,302
+21% +$260K 0.36% 134
2020
Q1 		$1.05M Buy
+136,098
New +$687K 0.33% 140
2019
Q1 		– Sell
-107,531
Closed -$869K – 267
2018
Q4 		$869K Sell
107,531
-39,653
-27% -$394K 0.24% 185
2018
Q3 		$1.9M Sell
147,184
-31,506
-18% -$395K 0.28% 155
2018
Q2 		$2.04M Buy
178,690
+92,723
+108% +$878K 0.32% 156
2018
Q1 		$606K Buy
+85,967
New +$650K 0.1% 255

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

EAM Investors's CTSO Position: Q3 2020 in Review

EAM Investors sold out of Cytosorbents Corp (CTSO) in Q3 2020, closing a stake of 164,400 shares — an estimated $1.63M sold.

EAM Investors first reported a position in CTSO in Q1 2018 and held it in 6 quarters. The position peaked at $2.04M in Q2 2018. 96 funds tracked by Wall St. Rank hold CTSO as of Q3 2020.

  • EAM Investors reported no remaining Cytosorbents Corp position as of Q3 2020 after selling out during the quarter.
  • EAM Investors sold 164,400 Cytosorbents Corp shares in Q3 2020, an estimated $1.63M.
  • EAM Investors first reported a position in Cytosorbents Corp in Q1 2018 and held it in 6 quarters.
  • EAM Investors's Cytosorbents Corp position peaked at $2.04M in Q2 2018.
  • 96 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2020.

Based on EAM Investors's 13F filing for Q3 2020, filed 13 Nov 2020.